Medication info
DURAB Tablet 30/2.5 mg (Pimasartan Potassium, Esamlodipine)

DURAB Tablet 30/2.5 mg (Pimasartan Potassium, Esamlodipine)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
White film-coated tablets with rounded edges
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300087 · Approved 2023.01.06

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose of fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or with this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be started with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Used in patients with essential hypertension when blood pressure is not sufficiently controlled by monotherapy with Pimasartan Potassium.

How to take

Adult dose

Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose of fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or with this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be started with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication can cause serious injury or death to the fetus or newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the main ingredients of this medication or similar drugs, those who are pregnant or breastfeeding, patients undergoing renal dialysis, patients with severely impaired liver function, those with biliary obstruction, certain kidney diseases or diabetes, those with lactose intolerance, patients with severe aortic stenosis, and those in a state of shock should not take this medication. Caution should be exercised when using this medication in patients with a deficient blood volume or low salt levels, impaired renal function, renal artery hypertension, patients with aortic or mitral valve stenosis, primary hyperaldosteronism, severe hypotension, the elderly, and those with allergies to certain pigments, as their condition should be closely monitored. Adverse effects such as dizziness, headache, facial or peripheral edema, urination disorders, insomnia, and flushing may occur; consult a physician if any unusual symptoms arise. There is a risk of serious adverse effects such as sudden drops in blood pressure, severe allergic reactions, and worsening renal function; therefore, caution is necessary. This medication can interact with other antihypertensive agents, diuretics, potassium-sparing drugs, certain anti-inflammatory drugs, antibiotics, lithium, grapefruit juice, etc.; notify your healthcare provider of all medications you are currently taking. It is advisable to avoid taking this medication during pregnancy or breastfeeding, but if necessary, consult a physician thoroughly. The safety and efficacy of this medication in children or adolescents under 18 years of age have not been established. No special dose adjustment is needed for elderly patients, but caution is advised due to potential sensitivity reactions. Patients with severely impaired liver function should not take this medication. In case of overdose, symptoms such as hypotension, palpitations, and in severe cases, shock may occur; immediate medical attention is necessary. This medication should be kept out of reach of children, and transferring it to another container may result in degradation of quality or accidental exposure, so caution is advised.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial edema
  • peripheral edema
  • urination disorder
  • insomnia
  • flushing
  • fainting
  • sedation
Show 133 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • increased liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • pruritus
  • local urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal adenocarcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute kidney failure
  • chronic kidney failure
  • renal stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of low back pain
  • osteoarthritis
  • arthralgia
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • increased blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • cancer recurrence
  • cerebral infarction
  • fracture
  • chest pain
  • weakness
  • fatigue
  • pain
  • weight gain/loss
  • hypotension
  • vasculitis
  • hypertonia
  • sensory decrease
  • sensory disturbance
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal symptoms
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • mood changes
  • dyspnea
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urination frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sick sinus syndrome
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin erythema
  • papular urticarial rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light and should be stored in a tightly closed container that blocks light. It is important to maintain the storage temperature between 1 to 30 degrees Celsius to preserve the drug's effectiveness and safety for an extended period.

Appearance and packaging

Appearance

White film-coated tablets with rounded edges

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.